FTC targets another CBD marketer for unsubstantiated disease claims
A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
The case brought against Arizona-based Kushly Industries LLC (Kushly) and the company’s sole officer Cody Alt is the seventh such enforcement brought by FTC against a CBD/hemp firm, according to Daniel Kaufman acting director of the FTC’s Bureau of Consumer Protection.
“There may be some benefits of CBD, but there’s no proof that it can treat the serious health conditions in Kushly’s advertising, such as Parkinson’s, multiple sclerosis, or cancer,” Kaufman said.